APVO - Aptevo Therapeutics EPS misses by $0.12 misses on revenue May, 11 2021 09:23 AM Aptevo Therapeutics Inc. Aptevo Therapeutics (APVO): Q1 GAAP EPS of -$1.74 misses by $0.12.Revenue of $2.42M misses by $10.65M.Press Release For further details see: Aptevo Therapeutics EPS misses by $0.12, misses on revenue